Tag: NOXA12
NOXXON Secures EUR 17 Million Extension Under Funding Agreement with Atlas to Develop NOX-A12 in Glioblastoma and Pancreatic Cancer Programs – 12/29/2021 at 6:00 PM
To receive all Noxxon news in real time, contact [email protected] Berlin, Germany, December 29, 2021, 6:00 p.m. CET – NOXXON Pharma NV (Euronext Growth Paris: ALNOX), a biotechnology company specializing…